Age, years, mean (SD) | 59.8 (6.2) |
Female, n (%) | 39 (65.0) |
Race/ethnicity, n (%) | |
Non-Hispanic black | 35 (58.3) |
Non-Hispanic white | 19 (31.7) |
Hispanic | 4 (6.7) |
Asian/Pacific Islander | 2 (3.3) |
Education, n (%) | |
High school or less | 10 (16.7) |
Some college, associate degree, or technical programme | 24 (40.0) |
College degree or more | 26 (43.3) |
Income, n (%) | |
≤$50 000 | 24 (40.0) |
$50 000 to $100 000 | 17 (28.3) |
>$100 000 | 17 (28.3) |
Missing | 2 (3.3) |
Diabetes duration, years, median (IQR) | 4.0 (3.5) |
Diabetes medication duration, years, median (IQR) | 4.0 (3.0) |
Hypertension duration, years, median (IQR) | 9.0 (7.5) |
Hypertension medication duration, years, median (IQR) | 8.0 (7.8) |
Glycated hemoglobin, per cent, mean (SD) | 7.0 (1.2) |
Systolic blood pressure, mm Hg, mean (SD) | 133.9 (17.0) |
Diastolic blood pressure, mm Hg, mean (SD) | 75.6 (11.5) |
Number of diabetes medication, mean (SD) | 1.2 (0.5) |
Number of hypertension medications, mean (SD) | 2.2 (1.0) |
Likelihood of starting an additional diabetes pill* | |
Very likely (≥7) | 43 (71.7) |
Somewhat likely (4–6) | 7 (11.7) |
Not likely (≤3) | 10 (16.7) |
Likelihood of starting an additional hypertension pill* | |
Very likely (≥7) | 41 (68.3) |
Somewhat likely (4–6) | 7 (11.7) |
Not likely (≤3) | 12 (20.0) |
*Response scale options ranged from 1=‘not likely’ to 10=‘very likely’.